| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
83,754,000 |
| Market
Cap: |
1.80(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$7.58 - $23.53 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kura Oncology is a clinical-stage biopharmaceutical company engaged in developing medicines for the treatment of cancer. Co.'s primary product candidate, ziftomenib, is a selective, reversible and oral small molecule inhibitor which blocks the interaction of two proteins, menin and the protein expressed by the Lysine K-specific Methyl Transferase 2A gene. Co.'s second product candidate, tipifarnib, is a selective and orally bioavailable inhibitor of farnesyl transferase. Co. is evaluating tipifarnib in multiple solid tumor and hematologic indications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
50,000 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$575,000 |
$575,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
2,615 |
111,517 |
111,517 |
128,117 |
| Total Sell Value |
$57,916 |
$2,235,730 |
$2,235,730 |
$2,468,998 |
| Total People Sold |
1 |
5 |
5 |
6 |
| Total Sell Transactions |
1 |
7 |
7 |
12 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wilson Troy Edward |
President and CEO |
• • – |
2020-10-07 |
4 |
AS |
$32.00 |
$3,196,800 |
I/I |
(99,900) |
106,736 |
|
-3% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-10-06 |
4 |
AS |
$32.00 |
$3,200 |
I/I |
(100) |
206,636 |
|
8% |
|
| Ford Kathleen |
Chief Operating Officer |
• – – |
2020-09-15 |
4 |
AS |
$29.43 |
$183,938 |
D/D |
(6,250) |
0 |
|
5% |
|
| Ford Kathleen |
Chief Operating Officer |
• – – |
2020-09-15 |
4 |
OE |
$19.43 |
$121,438 |
D/D |
6,250 |
6,250 |
|
- |
|
| Ford Kathleen |
Chief Operating Officer |
• – – |
2020-09-14 |
4 |
AS |
$29.43 |
$183,938 |
D/D |
(6,250) |
0 |
|
13% |
|
| Ford Kathleen |
Chief Operating Officer |
• – – |
2020-09-14 |
4 |
OE |
$19.43 |
$121,438 |
D/D |
6,250 |
6,250 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-14 |
4 |
AS |
$28.82 |
$2,838,876 |
I/I |
(98,490) |
206,736 |
|
13% |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-09-14 |
4 |
AS |
$29.00 |
$290,000 |
D/D |
(10,000) |
0 |
|
13% |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-09-14 |
4 |
OE |
$29.00 |
$290,000 |
D/D |
10,000 |
10,000 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-11 |
4 |
AS |
$28.00 |
$13,580 |
I/I |
(485) |
305,226 |
|
26% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-11 |
4 |
AS |
$28.00 |
$501,928 |
D/D |
(17,926) |
28,096 |
|
26% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-11 |
4 |
OE |
$6.15 |
$110,245 |
D/D |
17,926 |
46,022 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-10 |
4 |
AS |
$28.00 |
$1,036,840 |
D/D |
(37,030) |
28,096 |
|
28% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-10 |
4 |
OE |
$6.15 |
$227,735 |
D/D |
37,030 |
65,126 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-10 |
4 |
AS |
$28.00 |
$28,700 |
I/I |
(1,025) |
305,711 |
|
28% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-09-08 |
4 |
AS |
$26.00 |
$1,300,000 |
I/I |
(50,000) |
306,736 |
|
37% |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-09-08 |
4 |
AS |
$26.00 |
$260,000 |
D/D |
(10,000) |
0 |
|
37% |
|
| Grasso Marc |
CFO, CBO |
• – – |
2020-09-08 |
4 |
OE |
$15.47 |
$154,700 |
D/D |
10,000 |
10,000 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-19 |
4 |
AS |
$22.09 |
$263,196 |
D/D |
(11,913) |
28,096 |
|
50% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-19 |
4 |
OE |
$4.80 |
$57,182 |
D/D |
11,913 |
40,009 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-18 |
4 |
AS |
$22.00 |
$11,462 |
D/D |
(521) |
28,096 |
|
55% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-18 |
4 |
OE |
$4.80 |
$2,501 |
D/D |
521 |
28,617 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-17 |
4 |
AS |
$22.00 |
$283,868 |
D/D |
(12,901) |
28,096 |
|
53% |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-17 |
4 |
OE |
$4.80 |
$61,925 |
D/D |
12,901 |
40,997 |
|
- |
|
| Wilson Troy Edward |
President and CEO |
• • – |
2020-08-17 |
4 |
AS |
$22.00 |
$1,100,000 |
I/I |
(50,000) |
356,736 |
|
53% |
|
115 Records found
|
|
Page 3 of 5 |
|
|
0.32 (1.51%) 
